<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02397174</url>
  </required_header>
  <id_info>
    <org_study_id>DIEMED1</org_study_id>
    <nct_id>NCT02397174</nct_id>
  </id_info>
  <brief_title>Mediterranean Diet Versus Hypocaloric Diet in PCOS</brief_title>
  <official_title>Mediterranean Diet Versus Hypocaloric Diet: What is the Best Choice for the Treatment of Polycystic Ovary Syndrome (PCOS)?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Modena and Reggio Emilia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Polycystic ovary syndrome (PCOS) is the most common endocrinopathy of reproductive-aged women
      that manifests itself with chronic anovulation, hyperandrogenism and insulin resistance.
      Available guidelines recommend lifestyle intervention although they do not suggest the best
      dietetic regimen for the treatment of PCOS. Thus, the purpose of this study is to compare the
      effectiveness of two nutritional protocols, namely Mediterranean Diet and Hypocaloric Diet in
      PCOS women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PCOS is the most common endocrine disorder of reproductive age women, that is often
      associated with chronic anovulation, hyperandrogenism and insulin resistance. The central
      importance of insulin resistance in the pathogenesis of the syndrome has been established by
      several in vivo and in vitro studies. No data are available for the best therapeutical
      approach for metabolic dysfunction of PCOS. The new guidelines for the management of
      metabolic risk in PCOS strongly recommended that overweight/obese women with PCOS should lose
      weight changing their lifestyle. Although calorie-restricted diets are currently recommended
      to reach the healthy weight, there are still unsatisfied data regarding the best dietetic
      regimen that should be suggested.

      In this study, our purpose is to compare two nutritional protocols in order to find the best
      dietetic approach for improving clinical, metabolic and hormonal outcomes in pcos women.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>improvement in insulin resistance measured by HOMA index</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>composite improvement in clinical parameters (Body mass index, normalization of menses, hirsutism, waist to hip ratio);</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>composite improvement in metabolic parameters (total, LDL and HDL cholesterol);</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>composite improvement in hormonal parameters (Testosterone, Androstenedione, DHEAS, FSH, LH, beta estradiol)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>Mediterranean Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The diet programme will be characterized by carbohydrates (60 %); proteins (20 %, half comprised of vegetable proteins); total fat (20 %; saturated fat &lt; 10 %). After calculating the patient's energy need, the amount of calories will be successively adjusted to create an 800 kcal deficit per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hypocaloric diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The diet programme will be characterized by carbohydrates (50%),total lipids (30%) and proteins (20%). After calculating the patient's energy need, the amount of calories will be successively adjusted to create an 800 kcal deficit per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>mediterranean diet, restricted calorie</intervention_name>
    <description>50 pcos women will be assigned to hypocaloric mediterranean diet for 6 months</description>
    <arm_group_label>Mediterranean Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hypocaloric diet, restricted calorie</intervention_name>
    <description>50 pcos women will be assigned to standardized hypocaloric diet for 6 months</description>
    <arm_group_label>hypocaloric diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Polycystic ovary syndrome (using ESHRE/ARSM 2007 criteria)

          -  BMI &gt; 25

        Exclusion Criteria:

          -  Age &lt;18 or &gt;35 years

          -  BMI higher than 35

          -  Pregnancy

          -  Hypothyroidism, hyperprolactinemia, Cushing's syndrome, nonclassical congenital
             adrenal hyperplasia, use of oral contraceptives, glucocorticoids, antiandrogens,
             ovulation induction agents, antidiabetic or antiobesity drugs or other hormonal drugs
             within the previous 6 months

          -  Subjects with neoplastic, metabolic (including glucose intolerance), hepatic, and
             cardiovascular disorder or other concurrent medical illness (i.e. diabetes, renal
             disease, or malabsorptive disorders, cephalea)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesco Orio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco Orio, MD</last_name>
    <phone>+39 338 6759977</phone>
    <email>francescoorio@virgilio.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fertility Techniques SSD,Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona</name>
      <address>
        <city>Salerno</city>
        <zip>84131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Orio, MD</last_name>
      <phone>+39 338 6759977</phone>
      <email>francescoorio@virgilio.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Palomba S, Giallauria F, Falbo A, Russo T, Oppedisano R, Tolino A, Colao A, Vigorito C, Zullo F, Orio F. Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study. Hum Reprod. 2008 Mar;23(3):642-50. Epub 2007 Dec 23.</citation>
    <PMID>18158291</PMID>
  </results_reference>
  <results_reference>
    <citation>Palomba S, Falbo A, Giallauria F, Russo T, Rocca M, Tolino A, Zullo F, Orio F. Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial. Hum Reprod. 2010 Nov;25(11):2783-91. doi: 10.1093/humrep/deq254. Epub 2010 Sep 21.</citation>
    <PMID>20858697</PMID>
  </results_reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2015</study_first_submitted>
  <study_first_submitted_qc>March 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2015</study_first_posted>
  <last_update_submitted>April 18, 2016</last_update_submitted>
  <last_update_submitted_qc>April 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona</investigator_affiliation>
    <investigator_full_name>Francesco Orio</investigator_full_name>
    <investigator_title>prof</investigator_title>
  </responsible_party>
  <keyword>Polycystic Ovary syndrome</keyword>
  <keyword>hypocaloric diet</keyword>
  <keyword>Ovarian Cysts</keyword>
  <keyword>Ovarian Diseases</keyword>
  <keyword>Obesity</keyword>
  <keyword>Mediterranean Diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

